MicroPort Scientific Corp.

Company Snapshot

Founded: 1998
Entity Type: Public
Employees: 8,230
Region: China
Revenue: $950.7 Millions
Revenue Year: 2023
Headquarter: Shanghai, China
Key Geographics: China, North America, Europe, South America, Others, Asia
Corporate Address: 1601 Zhangdong Road Z.J. Hi-Tech Park, Shanghai, 201203 P.R. China Tel. +8621-389-54600 www.microport.com

Company Overview

Microport Scientific Corp. is one of the pioneered medical device companies engaged in designing, developing, and commercializing highly advanced medical devices. The company offers a wide range of products through its nine reportable segments – cardiovascular devices business, orthopedics devices business, cardiac rhythm management business, endovascular and peripheral, vascular devices business, neurovascular devices business, heart valve business, surgical robot business, surgical devices business, and others. It has over 8,230 employees and operates in approximately 100 countries.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

MicroPort Scientific Corp. In Reports

Microelectronic Medical Implants: Products, Technologies & Opportunities

BCC Research Market Analyst says global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029.

Medical Devices Industry: Competitive Landscape 2021

BCC Research Market Report for Medical Devices Industry. Discussion of the major market potential and opportunities in the medical devices industry.

Electroceuticals: Technologies and Global Markets

BCC Research Market Analysis Report Says electroceuticals market should reach $25.5 bln by the end of year 2022 and should reach more than $35.5 bln by year 2027

MicroPort Scientific Corp. In News

Company's Business Segments

  • Cardiovascular devices business : The cardiovascular devices business offers integrated solutions for the treatment of coronary artery-related diseases, and develops, manufactures and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories, active devices and other products
  • Orthopedics devices business : The orthopedics devices business offers overall solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments.
  • CRM business : This segment is principally engaged in developing, manufacturing and marketing products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, cardiac resynchronization therapy devices and supporting portfolio of monitoring products used in combination.
  • Endovascular and peripheral vascular devices business : The endovascular and peripheral vascular devices business focuses on providing integrated disease solutions for the interventional treatment of abdominal and thoracic aortic aneurysms, peripheral vascular diseases, aortic dissection aneurysms and other arteriovenous related diseases.
  • Neurovascular devices business : The neurovascular devices business provides solutions for the treatment of cerebrovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke, and in the R&D, production and commercialization of neurovascular therapeutic and access devices.
  • Heart valve business : This business segment includes four certified products: VitaFlow Transcatheter Aortic Valve Implantation and Delivery System , VitaFlow Liberty Transcatheter Aortic Valve Implantation and Retrievable Delivery System (including the procedural accessory products as their offerings), Alwide Plus Balloon Catheter and AccuSniper Double-Layer Balloon Catheter, and various transcatheter aortic valve implantation products, transcatheter mitral valve products, transcatheter tricuspid valve products and procedural accessory products at different development stages.
  • Surgical robot business : The surgical robot business is dedicated to providing robotic intelligent surgical total solutions and development needs of minimally invasive surgeries.
  • Surgical devices business : The MOBYBOX system.

Applications/End User Industries

  • Healthcare Professionals
  • Patients
  • Biotechnology
  • Medical Devices